dm+d
398728003
Articles
Choosing between available adalimumab products
22 February 2023
Understand the adalimumab products that are available on contract to the NHS. Choose between them appropriately for organisations or individuals.Safety in lactation: Drugs for chronic bowel disorders
21 September 2020
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…Safety in Lactation: Systemic preparations for eczema and psoriasis
7 January 2019
Drugs used orally or parenterally for severe eczema and psoriasis have a varied pharmacology, mainly either modifying the immune response to the disease or modifying…Lactation Safety Information
For rheumatoid arthritis
For rheumatoid arthritis
See summary
Moderate amount of published evidence of safety indicates small amounts in breast milk which are likely to be degraded in the infant’s GI tract
Long half-life increases risk of accumulation in breastfed infants
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
15 September 2019